AbbVie Inc. (ETR: 4AB)
Germany
· Delayed Price · Currency is EUR
168.06
+2.14 (1.29%)
Dec 20, 2024, 5:35 PM CET
AbbVie Revenue
AbbVie had revenue of $14.46B USD in the quarter ending September 30, 2024, with 3.83% growth. This brings the company's revenue in the last twelve months to $55.53B, up 0.72% year-over-year. In the year 2023, AbbVie had annual revenue of $54.32B, down -6.44%.
Revenue (ttm)
$55.53B
Revenue Growth
+0.72%
P/S Ratio
n/a
Revenue / Employee
$1.11M
Employees
50,000
Market Cap
297.86B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | 33.27B | 513.00M | 1.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAbbVie News
- 2 days ago - Kevin K Buckbee Executes Sell Order: Offloads $310K In AbbVie Stock - Benzinga
- 2 days ago - Retirement-Ready Income: 5 Dividend Gems I'd Buy If I Were 65 - Seeking Alpha
- 3 days ago - My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys - Seeking Alpha
- 3 days ago - Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo - Business Wire
- 4 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 4 days ago - AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? - Investor's Business Daily
- 5 days ago - Why Investors Should Watch AbbVie Inc (ABBV) - See It Market
- 5 days ago - AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors - Seeking Alpha